![Natasha Hernday](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Natasha Hernday
Directeur/Membre du Conseil chez
XOMA ROYALTY CORPORATION
Fortune : 669 314 $ au 31/05/2026
Profil
Natasha A. Hernday is an Independent Director at XOMA Royalty Corp.
since 2020 and an Independent Director at Janux Therapeutics, Inc. since 2024.
Former roles include Director-Mergers, Acquisitions & Out-Partnering at Amgen, Inc. from 1994 to 2010, Independent Director at PDL BioPharma, Inc. from 2019 to 2022, Independent Director at Alpine Immune Sciences, Inc. from 2020 to 2024, and Chief Business Officer at Seagen, Inc. from 2022 to 2023.
Education includes an MBA from Pepperdine University and undergraduate studies at the University of California, Santa Barbara.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2026 | 12 592 ( 0,1% ) | 525 212 $ | 31/05/2026 | |
| 21/05/2026 | 4 000 ( 0,41% ) | 101 820 $ | 31/05/2026 | |
| 15/02/2026 | 2 898 ( 0% ) | 42 282 $ | 31/05/2026 |
Postes actifs de Natasha Hernday
| Sociétés | Poste | Début |
|---|---|---|
| XOMA ROYALTY CORPORATION | Directeur/Membre du Conseil | 30/06/2020 |
| JANUX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 19/07/2024 |
Anciens postes connus de Natasha Hernday
| Sociétés | Poste | Fin |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Directeur/Membre du Conseil | 20/05/2024 |
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2023 |
| PDL BIOPHARMA, INC. | Directeur/Membre du Conseil | 01/12/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2010 |
Formation de Natasha Hernday
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
